Request Copyright Permission

Addressing China’s Growing Need for Inhaled Drugs: Development Strategies for Marketing, Distribution and Regulation

Li Y, Nagao L, Liu M, Webb K.

Respiratory Drug Delivery 2014. Volume 1, 2014: 131-142.

Abstract:

Patient access to medicines in China, the world’s most populous nation, differs significantly from that experienced in the US and Europe. Moreover, recent changes to regulatory approval processes and drug provision mechanisms have transformed the way drug manufacturers bring medicines to patients. Government actions aimed at increasing support for hospitals, health centers and pharmacies, as well as those bolstering insurance programs, and updating reimbursement lists will impact patient access. The following article expands on key developments in these areas and presents strategies for multinational pharmaceutical companies operating in this dynamic environment. Particular attention is paid to respiratory diseases and inhalation products; insights obtained via industry consortia collaborations are also shared.